Ipsen
Manufacturing · France · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
65 Quai Georges Gorse, Boulogne-Billanco...Phone Number
+33 158335000Website
www.ipsen.comRevenue
$4.4 BillionStock Symbol
IPNIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
11
1
2
2
2
2
About Ipsen
Founded in 1929 and headquartered in Boulogne, France, Ipsen Pharma is a global biopharmaceutical group focused on specialty care. The Group develops and commercializes medicines in therapeutic areas including oncology, neuroscience, and rare diseases.Explore more
Ipsen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ipsen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Ipsen has new funding data
Congratulate Masked Content for being promoted to Masked Content at Ipsen
Website visits: Recent activity has been detected on your website
Check out if Ipsen is spiking on competitors!
Check if Ipsen has recently received funding, and reach out quickly before it becomes old news!
Ipsen, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Ipsen launches new products
Earning: See what the market has to say on Ipsen recently announced quarterly report
Click to see if Ipsen had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Ipsen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ipsen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ipsen.
Ipsen Tech Stack
A closer look at the technologies used by Ipsen
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Open Position
Open Position
Open Position
Open Position
Ipsen News & Media
IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2026
Aggregated presentation by day and by marketIpsen provides update on Phase III BOLD trial in biliary atresia
PARIS, FRANCE, 24 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Phase III BOLD trial evaluating Bylvay versus placebo for patients living with biliary atresia (BA) who have already undergone a Kasai hepatoportoenterostomy (HPE) did not meet the primary endpoint of improvement in native liver survival vs placebo. Current topline data is in line with the well-established safety profile of odevixibat in approved indications. Characterized as a rapidly progressive and compleIpsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen's Rare Disease pipeline
PARIS, FRANCE, 22 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today it has completed the acquisition of Memo Therapeutics AG, a late-stage biotech company focused on potravitug, an anti-BK polyomavirus monoclonal antibody.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ipsen
Sign Up For FreeTo access detailed company insights
Founded in 1929 and headquartered in Boulogne, France, Ipsen Pharma is a global biopharmaceutical group focused on specialty care. The Group develops and commercializes medicines in therapeutic areas including oncology, neuroscience, and rare diseases.... Read More
